Syncona Portfolio Ltd 13D and 13G filings for Freeline Therapeutics Holdings plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-03-25 4:07 pm Purchase |
2022-03-15 | 13D | Freeline Therapeutics Holdings plc FRLN |
Syncona Portfolio Ltd | 2,524,143 62.270% |
1,269,841 (+101.24%) |
Filing |
| 2022-02-11 12:20 pm Unchanged |
2021-12-31 | 13G | Freeline Therapeutics Holdings plc FRLN |
Syncona Portfolio Ltd | 1,254,302 52.500% |
0 (Unchanged) |
Filing |
| 2021-02-12 11:04 am Purchase |
2020-12-31 | 13G | Freeline Therapeutics Holdings plc FRLN |
Syncona Portfolio Ltd | 1,254,302 54.200% |
1,254,302 (New Position) |
Filing |